Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015, we would like to inform you that the Board of Directors at its meeting held today i.e. November 14, 2024, has approved the appointment of Mr. Akalli Santosh Kumar as the Chief Financial Officer and Key Managerial Person of the Company with effect from November 14, 2024. The details as required under said Regulation and SEBI Circular dated July 13, 2023 is enclosed as Annexure I. This intimation is also being uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same.